Tofacitinib, a drug approved for treating rheumatoid arthritis, has been shown to be effective in treating vitiligo, an autoimmune disease that struck the late singer Michael Jackson.
Tofacitinib, a drug approved for treating rheumatoid arthritis, has been shown to be effective in treating vitiligo, an autoimmune disease that struck the late singer Michael Jackson.